{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:57:13Z","timestamp":1782226633312,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.metabol.2009.12.012","type":"journal-article","created":{"date-parts":[[2010,1,25]],"date-time":"2010-01-25T02:04:46Z","timestamp":1264385086000},"page":"1327-1330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis"],"prefix":"10.1016","volume":"59","author":[{"given":"Yusuf","family":"Yilmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesim Ozen","family":"Alahdab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oya","family":"Yonal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramazan","family":"Kurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla Eldeen","family":"Kedrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cigdem Ataizi","family":"Celikel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Ozdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Duman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nese","family":"Imeryuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erol","family":"Avsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Kalayci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2009.12.012_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10620-005-1267-z","article-title":"Nonalcoholic fatty liver disease: a clinical review","volume":"50","author":"Sass","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.metabol.2009.12.012_bib2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.tem.2008.08.005","article-title":"Insulin resistance, inflammation, and non-alcoholic fatty liver disease","volume":"19","author":"Tilg","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2009.12.012_bib3","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/jc.2006-0587","article-title":"Review: the role of insulin resistance in nonalcoholic fatty liver disease","volume":"91","author":"Utzschneider","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2009.12.012_bib4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","article-title":"The metabolic syndrome and chronic kidney disease in U.S. adults","volume":"140","author":"Chen","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2009.12.012_bib5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2009.12.012_bib6","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s001250050970","article-title":"Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome : the Hoorn study","volume":"41","author":"Jager","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2009.12.012_bib7","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1464-5491.1999.00059.x","article-title":"Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR)","volume":"16","author":"Balkau","year":"1999","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2009.12.012_bib8","article-title":"Impact of NAFLD on microalbuminuria in patients with prediabetes and diabetes","author":"Hwang","year":"2009","journal-title":"Intern Med J"},{"key":"10.1016\/j.metabol.2009.12.012_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF03349177","article-title":"Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients","volume":"29","author":"Targher","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.metabol.2009.12.012_bib10","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00467-009-1134-9","article-title":"Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease","volume":"24","author":"Manco","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.metabol.2009.12.012_bib11","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2009.12.012_bib12","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2009.12.012_bib13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.metabol.2007.11.022","article-title":"Nonalcoholic fatty liver disease predicts chronic kidney disease in non-hypertensive and non-diabetic Korean men","volume":"57","author":"Chang","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2009.12.012_bib14","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00125-008-0961-8","article-title":"What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?","volume":"51","author":"Satchell","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2009.12.012_bib15","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.2337\/db05-1484","article-title":"Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion","volume":"55","author":"Parvanova","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2009.12.012_bib16","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jhep.2006.03.005","article-title":"\u2018Endocrine NAFLD\u2019 a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis","volume":"44","author":"Lonardo","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2009.12.012_bib17","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s12325-008-0110-2","article-title":"Angiotensin receptor blockers in the treatment of NASH\/NAFLD: could they be a first-class option?","volume":"25","author":"Georgescu","year":"2008","journal-title":"Adv Ther"},{"key":"10.1016\/j.metabol.2009.12.012_bib18","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1665-2681(19)31822-8","article-title":"Metabolic syndrome and non-alcoholic fatty liver disease","volume":"8","author":"Almeda-Vald\u00e9s","year":"2009","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.metabol.2009.12.012_bib19","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1111\/j.1440-1746.2006.04659.x","article-title":"Molecular mechanisms of hepatic fibrogenesis","volume":"22","author":"Parsons","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2009.12.012_bib20","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/ndt\/gfn159","article-title":"Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and\/or angiotensin II receptor blocker","volume":"23","author":"Zhu","year":"2008","journal-title":"Nephrol Dial Transplant"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049509005241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049509005241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:49:48Z","timestamp":1758426588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049509005241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0026049509005241"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2009.12.012","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2009.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}